Amai Proteins, a pioneering Israeli food-tech enterprise, has announced the appointment of Doug Brown as its new Chief Executive Officer. This strategic leadership change is set to propel the company into a new era of growth, focusing on the accelerated commercial deployment of Sweelin, its innovative sweet protein ingredient. This move comes at a crucial time as global consumer preferences and regulatory pressures increasingly drive the demand for healthier, lower-sugar food and beverage options.
A New Chapter for Amai Proteins: Leadership, Innovation, and Market Impact
Doug Brown officially assumed his role on September 1, 2026, bringing with him a wealth of experience cultivated across the dynamic food, beverage, and dietary supplement sectors in both the United States and Europe. His distinguished career includes key positions such as chief commercial officer and head of global account management at Sirio Pharma and Best Formulations. Prior to these roles, he served as chief commercial officer at UK-based Clasado Biosciences and led business development for Nutritional Lipids at DSM Nutritional Products in Switzerland. This diverse background, encompassing multinational corporations and agile scale-up ventures, has equipped Brown with profound insights into commercial development, business-to-business partnerships, and international market expansion strategies.
Brown's immediate objective is to steer Amai Proteins through its forthcoming growth phase. He views Sweelin as a uniquely positioned solution for what he terms the "GLP-1/peptide era," indicating a significant market opportunity. Sweelin, a monellin-based sweet protein inspired by the serendipity berry, boasts an extraordinary sweetness profile, being approximately 3,000 times sweeter than conventional sugar by weight. Its production leverages precision fermentation, a cutting-edge technology increasingly adopted by food-tech companies to produce proteins and functional ingredients at a commercial scale. Unlike traditional sugar-reduction methods that often rely on complex blends of sweeteners, bulking agents, or taste-masking technologies, Amai Proteins positions Sweelin as a protein-based alternative that delivers intense sweetness at minimal inclusion levels. The ingredient has been meticulously developed to ensure stability, cost-effectiveness, and seamless compatibility with industrial food processing, making it suitable for a wide array of applications, including beverages, confectionery, chewing gum, condiments, and dietary supplements. This leadership transition underscores Amai Proteins' commitment to scaling up its operations following a period of intensive research, development, and strategic reorientation. Dr. Amir Guttman, the outgoing CEO, is acknowledged for his invaluable contributions during this foundational period and will continue to serve as an executive board member, maintaining his influence on the company's strategic direction.
The appointment of Doug Brown as CEO marks a pivotal moment for Amai Proteins. His extensive industry expertise and vision for Sweelin's commercialization are set to redefine the landscape of sugar reduction in the food and beverage industry. This move not only highlights Amai Proteins' innovative approach to developing sustainable and health-conscious ingredients but also signifies a broader trend in the food-tech sector towards advanced biotechnologies and strategic leadership to meet evolving consumer demands and regulatory standards. The focus on a single, highly potent ingredient like Sweelin, coupled with Brown's commercial acumen, positions Amai Proteins for significant market disruption and sustainable growth.